GCG and type 2 diabetes mellitus: Therefore, as the GLP-1 RAs expand into non-T2DM indications such as obesity metabolic syndrome and other related conditions, controlled studies and better understanding of the molecular mechanisms of action are necessary to investigate this association and prevent potential serious consequences.